By Leslie Carol Botha In a long awaited decision1 the US FDA has ruled against Merck’s supplemental biologics license application (sBLA) for an indication to use GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] in women ages 27-45. This was Merck’s 4th request to expand Gardasil use to an older population […]
Effects of pneumococcal vaccination program on pneumococcal carriage and invasive disease
Using a cross-sectional study, Stefan Flasche and colleagues investigated the effects of the UK pneumococcal vaccination program on serotype-specific carriage and invasive pneumococcal disease. There are more than 90 Streptococcus pneumoniae serotypes that can cause invasive pneumococcal disease (IPD). The pneumococcal conjugate vaccine PCV7 contains antigens from seven serotypes responsible for IPD. Immunization with PCV7 […]
Updates on the management of cervical pre-cancer discussed at Obs-Gyne expo
Currently cervical cancer accounts for 10% of all cancers worldwide, ranking as the third most commonly diagnosed cancer in the world. According to Prof. F. Xavier Bosch from the Cancer Epidemiology and Research Program at the Catalan Institute of Oncology in Barcelona, the idea that the MENA region is at low risk from gynaecological cancers […]
Vaccinations Attack Cervical Cancer
By Bana Qabbani DUBAI // Expatriate schoolgirls are to be targeted by health officials aiming to increase the number of pupils who receive vaccinations for cervical cancer. Although uptake has been high among Emirati girls, officials say far fewer students from abroad have opted to take the treatment. Now in its fourth year, the school-based […]
U.S. Prescribing Information for GARDASIL® Updated; Indication Not Granted for Use in Adult Women
Merck News Room April 6, 2011 WHITEHOUSE STATION, NJ – April 6, 2011 – Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has completed its review of Merck’s supplemental biologics license application (sBLA) for an indication to use GARDASIL [Human Papillomavirus […]
- « Previous Page
- 1
- …
- 204
- 205
- 206
- 207
- 208
- …
- 393
- Next Page »
